NCT00531804View on ClinicalTrials.gov

A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Alzheimer's Disease
Interventions
DRUG

gantenerumab

Administered iv at escalating doses (7 cohorts)

Trial Locations (9)

2100

Copenhagen

14186

Stockholm

20502

Malmo

52621

Ramat Gan

1081 GM

Amsterdam

FY20JH

Blackpool

G20 0XA

Glasgow

SO30 3JB

Southampton

SN3 6BW

Swindon

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00531804 - A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease. | Biotech Hunter | Biotech Hunter